Axa’s Affirm AFRM Stock Holding History

Axa’s Portfolio AFRM Stock Details AFRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-49,818	Closed	-$3.44M	–	90
2025 Q2	$3.44M	Buy	49,818 +39,509	+383%	+$2.05M	0.01%	644
2025 Q1	$466K	Buy	+10,309	New	+$611K	﹤0.01%	937

Other funds holding AFRM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Axa's AFRM Position: Q3 2025 in Review

Axa sold out of Affirm (AFRM) in Q3 2025, closing a stake of 49,818 shares — an estimated $3.44M sold.

Axa first reported a position in AFRM in Q1 2025 and held it in 2 quarters. The position peaked at $3.44M in Q2 2025. 615 funds tracked by Wall St. Rank hold AFRM as of Q3 2025.

Axa reported no remaining Affirm position as of Q3 2025 after selling out during the quarter.
Axa sold 49,818 Affirm shares in Q3 2025, an estimated $3.44M.
Axa first reported a position in Affirm in Q1 2025 and held it in 2 quarters.
Axa's Affirm position peaked at $3.44M in Q2 2025.
615 funds tracked by Wall St. Rank held Affirm as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.